Every company has
a point where its
trajectory bends.
We work there.
Keyflexion provides expertise as a service to founders, innovators, leadership teams and investors. We navigate complexity at key inflection points, execute the strategy and deliver tangible outcomes. You work with the owners, not juniors.
What sets us apart is that we’ve actually done it.
We have navigated the path from early technology to commercialisation as chief executives, operators, dealmakers, finance leaders and directors. Each principal brings several disciplines rather than a single specialism, so you get senior judgement across science, technology, commercial, capital and governance from one small team, and you deal directly with the people doing the work.
One team, start to finish
Global experience. Local commitment.
The people who scope the work do the work, and stay on it. You are not handed to a delivery team, and you do not brief a new face every few weeks.
Because we’ve walked it
Growth, transformation, capital raising, transactions and commercialisation — we’ve led organisations through critical business moments because we’ve done it ourselves, not simply advised from the outside.
No set formula
We solve the specific problem in front of you and shape every engagement around your organisation, its market and its stage — then give you the structure and framework to grow.
The problems we get
called in to solve.
Most of our work starts with one of these. If any of them sounds like your position, we are worth a conversation.
The experience behind the advice.
Five ways in, one team.
Wherever you are between early innovation and commercial success, we meet you there — with advice, hands-on delivery, deal capability, governance judgement or an independent read on an investment.
Start-ups, founders, and the people backing them.
Most of our work starts early — a founder with technology and a plan, an investor weighing a decision, a leadership team entering a market they haven’t sold to before. We come in at that stage and stay until it is commercial. Increasingly that includes family offices and private investors weighing early-stage technology. For selected opportunities we can structure engagements as a combination of fees and equity — investing our expertise alongside founders and sharing in the value we help create.
Across the sectors turning technology into products.
From early technology to products in the market — with founders, innovators and investors across different sectors, with deep knowledge in health and life sciences; the same commercialisation discipline applies wherever the technology comes from.